Aridian (@Aridian397) header
Aridian (@Aridian397) profile picture

growth/tech/cloud stock investor

US
Joined December 2021
Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)Photo by Aridian (@Aridian397)
Replying to @ChicagoBears
CHEESE GRATER HAT LMAAAOOOOO
16
114
4
2,637
50,901
All Packers fans tonight And when they wake up tomorrow? They still live in WI…
2
1
188
Esperion’s Bempedoic Acid Receives Recommendation in 2025 ACC Scientific Statement on Management of Peripheral Artery Disease in Adults With Diabetes. Read More: bit.ly/4oZg83f
3
1
10
555
Not a lot of QBs are great at throwing it away, he does a good job for a young QB!
2
1
151
$ESPR nothing about shareholders, eh? Yup…screw those retail shareholder peasants. Dilute them again, Sheldon & Ben!! “Cash position is GREAT” they said in September. #Ethics. @EsperionInc
At Esperion, our core values guide everything we do from discovery to delivery.
1
5
1,082
$ESPR cool story, bro…
Replying to @rumourbuyouts
Was this deleted? If so, why? $ESPR
1
1
360
Aridian retweeted
$ESPR More good news for Bempedoic Acid which has been shown to lower hsCRP with its anti inflammatory benefits unlike the injectables.
A long-awaited consensus statement on inflammation and heart disease "We have thus entered an era when the evidence linking inflammation with ASCVD is no longer exploratory but is compelling and clinically actionable." @JACCJournals open-access jacc.org/doi/10.1016/j.jacc.…
1
4
903
$ESPR US sales already 40-50% y/y, with positive guideline updates expected in Q1-26. Yellow is my projections.
$ESPR Europe sales were ALREADY doing the below. And guidelines were just favorably updated!
3
8
1,538
$ESPR Europe sales were ALREADY doing the below. And guidelines were just favorably updated!
$MRK $ESPR Nothing more impactful on MACE than elevated hsCRP, particularly above 2mg/dL. Like blood pressure, hsCRP is “transient”, with spikes and drops, but quite consistent in its baseline. PCSK9 inhibitors have no effect on hsCRP. That is not great for MACE outcomes.
3
1
5
2,298
Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias. Read more: bit.ly/3JJeu6V
6
1
19
1,157
$ESPR It looks like the big (5,000 participants) MILOS study will be wrapping up in just over a week from now. Some cohorts’ data were released over the past couple years. I’m anticipating a comprehensive release with a lot of new outcome data. clinicaltrials.gov/study/NCT…
1
4
9
604
Good news: i did it under 10 min. Meh news: barely. Got some work to do on the chinup front!
Replying to @mariolawrencejr
agreed. I do chinup sets typically 13, 9, and 8 reps each. So that is 31 I know I can do under 10 min. I think I only need 2.5-3 min total for the 100 pushups, but maybe 1 set 50, then do all the chinups with rest. then final set 50. So 7 min for 50 chinups? Am over 50.
165
$ESPR Imagine a combination therapy that yields >60% LDL-C reduction and an hsCRP reduction from a median (n=73) of 10mg/L to 0.48 mg/L in one month. That’s what REB (40mg rosuvastatin + Ezetimibe 10mg + Bempedoic acid 180mg) can accomplish. researchgate.net/publication…
2
1
9
1,066
I prefer to stick to the science, but I would be a fool if I didn’t comment on the obvious. A sustained rate of growth in EU sales will make Nilemdo/ Nustendi a blockbuster by 2028. Royalties will revert back to $ESPR around same time. At 20% royalties, do the math.
$ESPR DSE Q2 European sales of bempedoic acid $84.6M daiichisankyo.com/files/inve…
1
5
1
13
1,664
$ESPR Huge if true!!
$ESPR huge rumor floating around: former CMO Foody at the center of it. Possibly massive buyout, as no other way to explain her exit package. Forget drugs, patents, and sales…everything has been driving towards getting the former CMO paid! Source: stocktwits
1
3
393